about
Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start HemodialysisAnemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease.Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality.Improving prognosis estimation in patients with heart failure and the cardiorenal syndromeNontraditional cardiovascular biomarkers and estimation of cardiovascular risk in predialysis chronic kidney disease patients and their correlations with carotid intima media thickness.NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study.MicroRNAs in patients on chronic hemodialysis (MINOS study).NT-proBNP: is it a more significant risk factor for mortality than troponin T in incident hemodialysis patients?Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis PatientsCardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.Which Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational StudyCardiovascular disease in patients with chronic kidney disease: a neglected subgroup.Isolated cardiac troponin rise does not modify the prognosis in elderly patients with hip fracture.Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay.Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease.Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report.Does percutaneous nephrolithotomy cause elevated cardiac troponins?Oral health and systemic inflammatory, cardiac and nitroxid biomarkers in hemodialysis patients.Prognostic Significance of Elevated Cardiac Troponin in Acute Gastrointestinal BleedingHypertension, fluid overload and micro inflammation are associated with left ventricular hypertrophy in maintenance hemodialysis patients.Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management.Bio-width index: a novel biomarker for prognostication of long term outcomes in patients with anaemia and heart failure.High-sensitivity cardiac troponin T in obstructive sleep apnea patients without cardiovascular diseases: Efficacy of CPAP treatment.Prognostic value of plasma NT-proBNP levels in very old patients with moderate renal insufficiency in China.Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.High risk endovascular aneurysm repair: a case report.Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?.Effects of lowered dialysate sodium on left ventricle function and brain natriuretic peptide in maintenance of hemodialysis patients.Are levels of brain natriuretic peptides useful to determine volume status in dialysis patients?Troponin I Levels in Asymptomatic Hemodialysis Patients.Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.Application of speckle-tracking echocardiography in detecting coronary artery disease in patients with maintenance hemodialysis.Multiplexed MRM-based assays for the quantitation of proteins in mouse plasma and heart tissue.The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease
P2860
Q28468444-710C2FA4-B0BE-4016-8B9B-86A12C570635Q33899258-14A75508-4780-4566-9D2B-923AF201BC78Q34451008-32D3FC59-C2A9-4A35-81C1-CAAF9C058571Q35020305-4256B458-3D64-4215-AD57-8C3A232DD824Q35089780-407EAD89-7E0A-4A42-B707-169605C40667Q35508045-E48CC6A6-BDD6-4780-93E9-89CDBE756F81Q35591500-E0D0CEAC-5644-4D6A-B1DA-A62E29BCA4D1Q35860686-E5CD0F06-1C83-42FB-B9D8-650C4C2A1474Q36152500-C8025A38-9BA8-47C6-9B42-F7B5D18BA2C1Q36476324-7BFBDB3D-8257-4DA2-86F7-DE4CA78706DCQ36551359-DBB40ED7-AE55-4978-BC97-1054708D2ACDQ36945030-0C8A222C-C1A4-4816-80F2-4D5C66D02D8AQ37026079-11FA9E68-9AEF-4DB8-9317-ECFB33DC8026Q37463969-962A2490-0FA5-493D-AE84-9D83F6CEA739Q37656393-B6A90493-BFF5-4EF1-AF83-2E8313221D47Q37951798-397376AF-6127-4C90-8623-845C2CEC0967Q39655768-33925179-69BE-4DEE-8CF9-39F11F555C04Q40590600-91E47E1F-D71C-42B5-9C21-994075BEDCEEQ40671675-163CFBBA-0EB8-4869-9863-50F55260C0D8Q40872573-E67C5B91-4840-44DF-9844-6CCF78232DF0Q40889777-329BBA67-345B-4304-9477-A8B81988D8C8Q41320632-F981A21C-847E-49E8-9ED1-D86CA1C23592Q41353159-59960526-8507-43E4-ABCA-D912EA684E4DQ44459137-4EBEB892-2822-49B6-A181-AFBC4D37D29FQ46335976-C76D4F72-3618-48EC-AF9E-9EAFB3227DE2Q47352675-B8FCBF2D-B00B-43D1-ADB2-251C56FA8CA7Q47664834-A5757BEE-52D5-4F87-A8B9-2E25DBC3632DQ48007330-018003A6-5BF7-4BBE-A4F0-AE3DE1F44A06Q48035139-04194E11-5156-4F83-B235-569608701D5DQ48261282-8383ED58-BC76-4B4C-8E96-178842AFFDB0Q48316820-474ED3E8-5C36-4FEC-ACED-2826B5EB2769Q48809600-E11A74F7-57E8-4DDD-A921-C600E7C1F7A1Q48944257-537A9DAA-8B34-4E7B-9E46-1D57BAAEE25EQ49677711-EA2BB5A5-3370-4574-A895-A223696DD422Q50502242-A60D9C4C-862C-44A0-B02E-4B65097C44AAQ50688428-BA28E024-D9A9-4CC0-BC2F-44FA12856A67Q51149956-1395F480-C706-42E9-8AC0-F68F1934417DQ58722934-7C6EA026-2416-4D30-AB62-A7650268EF95
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of cardiac biomarkers in end-stage renal disease.
@en
Use of cardiac biomarkers in end-stage renal disease.
@nl
type
label
Use of cardiac biomarkers in end-stage renal disease.
@en
Use of cardiac biomarkers in end-stage renal disease.
@nl
prefLabel
Use of cardiac biomarkers in end-stage renal disease.
@en
Use of cardiac biomarkers in end-stage renal disease.
@nl
P356
P1476
Use of cardiac biomarkers in end-stage renal disease.
@en
P2093
Angela Yee-Moon Wang
Kar-Neng Lai
P304
P356
10.1681/ASN.2008010012
P577
2008-03-05T00:00:00Z